Jenburkt Pharmaceuticals Ltd. (JENBURPH)
Market Closed
15 Oct, 10:00 PM
MSE MSE Primary ₹
916. 00
+1
+0.1093%
₹
4.45B Market Cap
20.75 P/E Ratio
72% Div Yield
4 Volume
0 Eps
₹ 915
Previous Close Want to track JENBURPH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Jenburkt Pharmaceuticals Ltd. (JENBURPH) Statistics
Valuation metrics
Market Cap 4.45B
Enterprise value 4.17B
Trailing P/E (ttm) 12.7
Forward P/E 28.99
PEG ratio 10.49
Price/Sales (ttm) 2.47
Price/Book (mrq) 2.12
Enterprise Value/Revenue 2.47
Enterprise Value/EBITDA 9.25
Overview
Shares outstanding 4.41M
Float 1.26M
Shares short -
% Held by insiders 0.64%
% Held by institutions -
Average volume (10 days) 423
Average volume (90 days) 1.09K
Price summary
52-Week low 880.1
52-Week high 1,321
Beta 0.31
50-Day moving average 991.04
200-Day moving average 1,070.99
Dividends and splits
Forward annual dividend rate 72
Forward annual dividend yield 0.0712%
Trailing annual dividend rate 20.7
Trailing annual dividend yield 0.0219%
5-Year annual dividend yield 2.04%
Payout ratio 0.24
Dividend Date 28 Aug 2026
Ex-Dividend Date 28 Aug 2026
Last split factor -
Last split Date -
Financials
Fiscal year
Fiscal year ends 31 Mar 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin 0.19%
Operating margin 0.22%
Operational effectiveness
Return on assets 0.15%
Return on equity 0.17%
Income Statement
Revenue (ttm) 1.65B
Revenue per share (ttm) 382.31
Quarterly revenue growth (yoy) 0.17%
Gross profit (ttm) 1.32B
EBITDA 433.27M
Net income to common (ttm) 324.23M
Diluted EPS (ttm) 74.39
Quarterly earnings growth (yoy) -0.09%
Balance Sheet
Total cash (mrq) 96.48M
Total cash per share (mrq) 107.21
Total debt (mrq) 17.08M
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 4.11%
Book value per share (mrq) 446.47
Cash Flow
Cash flow statement 252.79M
Levered free cash flow (LFCF) 320.61M
2026 © Marketlog. All Rights Reserved.
